Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Helios University Hospital Wuppertal
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Providence Health & Services
City of Hope Medical Center
Thomas Jefferson University
Spanish Breast Cancer Research Group
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Regina Elena Cancer Institute
University Medical Center Groningen
University of Nebraska
Georgetown University
Rutgers, The State University of New Jersey
Wake Forest University Health Sciences
Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt University
Rutgers, The State University of New Jersey
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Leeds
NRG Oncology
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of South Florida
Abramson Cancer Center at Penn Medicine
University of Southampton
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Case Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
University of Washington
University of Washington
University of California, San Francisco
University of Washington
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
Stanford University
University of Washington